CTOs on the Move

Hospice of Michigan

www.hom.org

 
With roots dating back to the 1970s, we are the most experienced provider of hospice care in Michigan. Currently serving more than 1,700 patients daily, in 56 counties, we`re also the largest in our state, and among the largest recognized 501c3 non-profit advanced illness management organizations in the nation. We provide care for all—regardless of age, diagnosis, or ability to pay. Last year, our commitment extended $4 million beyond what was reimbursed by insurance. Because we welcome those who are uninsured, or whose treatment is more expensive than what other hospices can provide, we depend on the financial support of our ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.hom.org
  • 400 Mack Avenue
    Detroit, MI USA 48201
  • Phone: 313.578.5000

Executives

Name Title Contact Details

Similar Companies

Nutramax Laboratories

Nutramax Laboratories, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Nutramax Laboratories, Inc. is based in Edgewood, MD. You can find more information on Nutramax Laboratories, Inc. at www.nutramaxlabs.com

Elmore Medical Center Foundation Inc

Elmore Medical Center Foundation Inc is a Mountain Home, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MintHealth

A global decentralized health platform that empowers patients with a self-sovereign health identity and aligns patients, providers, and payers to battle the global pandemic of chronic disease

Endologistic

Endologistic is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.